阿克尔曼西亚菌 (Akkermansia muciniphila) 通过调节免疫微环境来改善胃癌治疗
Jianming Fang1, Huizhong Zhang1, Xiaodong Zhang1
1Department of Hepatobiliary Pancreatic Surgery, GuangFu Oncology Hospital, Jinhua, 321000, China.
Future microbiology
|April 17, 2024
概括
Akkermansia muciniphila外膜蛋白质促进胃癌细胞的亡,并增强抗瘤免疫力. 这表明Akkermansia muciniphila可以通过调节免疫微环境来改善胃癌治疗.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 肠道微生物群在癌症的发展和进展中起着至关重要的作用.
- 在Akkermansia muciniphila (AKK) 和癌症免疫疗法疗效之间存在强烈的关联.
研究的目的:
- 研究AKK及其外膜蛋白对胃癌 (GC) 的影响.
- 评估AKK在调节瘤免疫微环境中的潜力,以改善GC治疗.
主要方法:
- 在体外和体内实验中使用GC细胞系和动物模型进行了体外和体内实验.
- 检测包括细胞计数套件-8,流动细胞计量,西部涂抹,ELISA,免疫组织化学和免疫光.
主要成果:
- AKK外膜蛋白在GC细胞中诱导了亡.
- AKK表现出免疫刺激作用,促进M1巨细胞两极分化,增强细胞毒性T淋巴细胞反应,同时抑制Treg活性.
- AKK抑制了GC瘤的生长,并增加了瘤组织中的免疫细胞透.
结论:
- AKK及其外膜蛋白显示出对胃癌的治疗潜力.
- 用AKK调节免疫微环境可以改善GC治疗结果.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
What is Monogastric Digestion?
71.1K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.1K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
